NEW YORK , Feb. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tungray Technologies Inc (NASDAQ: TRSG) resulting from allegations that Tungray Technologies may have issued materially misleading business information to the investing public. So What: If you purchased Tungray Technologies securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK , Feb. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Dave Inc. (NASDAQ: DAVE) resulting from allegations that Dave may have issued materially misleading business information to the investing public. So What: If you purchased Dave securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK , Feb. 17, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Elastic N.V. (NYSE: ESTC) between May 31, 2024 and August 29, 2024, both dates inclusive (the "Class Period").

NEW YORK , Feb. 17, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the "Class Period"), of the important March 14, 2025 lead plaintiff deadline. So what: If you purchased Pacira securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”), of the important March 25, 2025 lead plaintiff deadline.

Fourth Quarter Highlights Fourth quarter 2024 net loss attributable to Huntsman of $141 million compared to net loss of $71 million in the prior year period; fourth quarter 2024 diluted loss per share of $0.82 compared to diluted loss per share $0.41 in the prior year period. Fourth quarter 2024 adjusted net loss attributable to Huntsman of $43 million compared to adjusted net loss of $36 million in the prior year period; fourth quarter 2024 adjusted diluted loss per share of $0.25 compared to adjusted diluted loss per share of $0.21 in the prior year period.

NEW YORK , Feb. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class Period"), of the important March 25, 2025 lead plaintiff deadline. So what: If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130109&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=130110&wire=1 or contact Joseph E. Levi, Esq.

CHARLOTTE, N.C. , Feb. 17, 2025 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD) ("JELD-WEN" or the "Company") today announced results for the quarter and year ended December 31, 2024.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Intellia Therapeutics, Inc. (NASDAQ:NTLA) between July 30, 2024 and January 8, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

indie Semiconductor specializes in automotive semiconductors and software for advanced driver assistance systems, positioning itself in a high-growth market. The company's focus on innovation and strategic partnerships enhances its competitive edge and growth potential. Risks include market volatility and dependency on the automotive industry's adoption of advanced technologies.

MINNEAPOLIS--(BUSINESS WIRE)--Tennant Company ("Tennant" or the "Company") (NYSE: TNC) today reported its fourth-quarter and full-year financial results for 2024. (In millions, except per share data) Three Months Ended December 31, Twelve Months Ended December 31, 2024 2023 Incr / (Decr) 2024 2023 Incr / (Decr) Net sales $ 328.9 $ 311.4 5.6 % $ 1,286.7 $ 1,243.6 3.5 % Net income $ 6.6 $ 31.0 (78.7 )% $ 83.7 $ 109.5 (23.6 )% Dilut.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=130105&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your FMC Corporation (NYSE:FMC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fmc-corporation-lawsuit-submission-form?prid=130106&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=130103&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=130104&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=130102&wire=1 or contact Joseph E. Levi, Esq.

CHARLOTTE, N.C. , Feb. 17, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that Kent Masters, chairman and CEO, is scheduled to present at the BMO Capital Markets 2025 Global Metals, Mining & Critical Materials Conference on Monday, Feb. 24, at 3 p.m.

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=130107&wire=1 or contact Joseph E. Levi, Esq.